AU2003296878A1 - Methods to administer epothilone d - Google Patents

Methods to administer epothilone d

Info

Publication number
AU2003296878A1
AU2003296878A1 AU2003296878A AU2003296878A AU2003296878A1 AU 2003296878 A1 AU2003296878 A1 AU 2003296878A1 AU 2003296878 A AU2003296878 A AU 2003296878A AU 2003296878 A AU2003296878 A AU 2003296878A AU 2003296878 A1 AU2003296878 A1 AU 2003296878A1
Authority
AU
Australia
Prior art keywords
epothilone
administer
methods
administer epothilone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003296878A
Other languages
English (en)
Other versions
AU2003296878A8 (en
Inventor
Alison Hannah
Robert G. Johnson
Michael Sherrill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kosan Biosciences Inc
Original Assignee
Kosan Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kosan Biosciences Inc filed Critical Kosan Biosciences Inc
Publication of AU2003296878A1 publication Critical patent/AU2003296878A1/en
Publication of AU2003296878A8 publication Critical patent/AU2003296878A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2003296878A 2002-05-20 2003-05-20 Methods to administer epothilone d Abandoned AU2003296878A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38216602P 2002-05-20 2002-05-20
US60/382,166 2002-05-20
PCT/US2003/017921 WO2004103267A2 (en) 2002-05-20 2003-05-20 Methods to administer epothilone d

Publications (2)

Publication Number Publication Date
AU2003296878A1 true AU2003296878A1 (en) 2004-12-13
AU2003296878A8 AU2003296878A8 (en) 2009-01-08

Family

ID=33476529

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003296878A Abandoned AU2003296878A1 (en) 2002-05-20 2003-05-20 Methods to administer epothilone d

Country Status (7)

Country Link
US (1) US20040072882A1 (https=)
EP (1) EP1575556A2 (https=)
JP (1) JP2006514681A (https=)
KR (1) KR20050043796A (https=)
CN (1) CN101389334A (https=)
AU (1) AU2003296878A1 (https=)
WO (1) WO2004103267A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001124A1 (en) * 1996-12-03 1999-01-14 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US20020058286A1 (en) * 1999-02-24 2002-05-16 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
US8618085B2 (en) * 2000-04-28 2013-12-31 Koasn Biosciences Incorporated Therapeutic formulations of desoxyepothilones
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
DE60330407D1 (de) * 2002-08-23 2010-01-14 Sloan Kettering Inst Cancer Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung
US6921769B2 (en) 2002-08-23 2005-07-26 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
AU2004268377B2 (en) * 2003-09-02 2008-06-26 Novartis Ag Cancer treatment with epothilones
US20050171167A1 (en) * 2003-11-04 2005-08-04 Haby Thomas A. Process and formulation containing epothilones and analogs thereof
US20050215604A1 (en) * 2004-03-26 2005-09-29 Kosan Biosciences, Inc. Combination therapies with epothilones and carboplatin
EP2634252B1 (en) 2005-02-11 2018-12-19 University of Southern California Method of expressing proteins with disulfide bridges
US8008256B2 (en) * 2006-05-01 2011-08-30 University Of Southern California Combination therapy for treatment of cancer
JP5718808B2 (ja) * 2008-04-25 2015-05-13 エーエスエム インターナショナル エヌ．ヴェー．Ａｓｍ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｎ．Ｖ． テルルおよびセレン薄膜のａｌｄのための前駆体の合成および使用
WO2010056901A2 (en) 2008-11-13 2010-05-20 University Of Southern California Method of expressing proteins with disulfide bridges with enhanced yields and activity
JP5731519B2 (ja) 2009-10-26 2015-06-10 エーエスエム インターナショナル エヌ．ヴェー．Ａｓｍ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｎ．Ｖ． Ｖａ族元素を含む薄膜のａｌｄのための前駆体の合成及び使用
AU2011255647A1 (en) 2010-05-18 2012-11-15 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69735057T2 (de) * 1996-03-12 2006-08-31 PG-TXL Co., L.P., Houston Wasserlösliche paclitaxel-prodrogen
WO1999001124A1 (en) * 1996-12-03 1999-01-14 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
KR100574454B1 (ko) * 1997-12-04 2006-04-27 브리스톨-마이어즈 스퀴브 컴페니 옥시라닐 에포틸론을 환원시켜 올레핀계 에포틸론을 제조하는 방법
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
US6302838B1 (en) * 1998-02-25 2001-10-16 Novartis Ag Cancer treatment with epothilones
NZ511722A (en) * 1998-11-20 2004-05-28 Kosan Biosciences Inc Recombinant methods and materials for producing epothilone and epothilone derivatives
US6664288B1 (en) * 1999-04-14 2003-12-16 Dana Farber Cancer Institute, Inc. Method and composition for the treatment of cancer
CA2401800A1 (en) * 2000-03-01 2001-09-07 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
EP1652926B1 (en) * 2000-04-28 2009-09-30 Kosan Biosciences, Inc. Crystalline epothilone d
EP1303615A2 (en) * 2000-07-25 2003-04-23 Kosan Biosciences, Inc. Fermentation process for epothilones

Also Published As

Publication number Publication date
US20040072882A1 (en) 2004-04-15
JP2006514681A (ja) 2006-05-11
AU2003296878A8 (en) 2009-01-08
WO2004103267A2 (en) 2004-12-02
EP1575556A2 (en) 2005-09-21
CN101389334A (zh) 2009-03-18
WO2004103267A3 (en) 2008-11-27
KR20050043796A (ko) 2005-05-11

Similar Documents

Publication Publication Date Title
AU2003901345A0 (en) Improved cannula
AU2003239909A1 (en) Enhanced-service provision
AU2002329877A1 (en) Cross reference to related art
AU2003215209A1 (en) Syringe
AU2003259457A1 (en) Auto-destructible syringe
AU2003291889A1 (en) Footing form
AU2003283626A1 (en) Catheter
AU2003296878A1 (en) Methods to administer epothilone d
AUPS160602A0 (en) Therapeutic method
AU2003218107A1 (en) C12-cyano epothilone derivatives
AU2003294938A1 (en) Epothilone derivatives
AUPS239302A0 (en) Improvements to tow-bars
AU2003260148A1 (en) Aquarium
AU2003244140A1 (en) Catheter
AU2003255727A1 (en) Syringes
AU2003255139A1 (en) Tractor
AU2003264722A1 (en) Methods
AU2003292682A1 (en) Catheter
AU2003255137A1 (en) Tractor
AU2003268985A1 (en) Cannula
AU2003231937A1 (en) Therapeutic methods
AU2003211854A1 (en) Putter
AU2003255138A1 (en) Tractor
AU2003255140A1 (en) Tractor
AU2003253469A1 (en) Putter

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase